Latest news

Poo transplants could be the answer to antibiotic resistance and save the lives of liver disease patients
Scientists have launched a new study that will investigate whether poo transplants could cut the risk of serious complications from advanced liver disease. The exciting research may also have important implications for global health ...

Tackling antibiotic resistance in people with chronic liver disease: could a poo transplant be the answer?
PROMISE – Fecal Microbiota Transplant (FMT) Trials (fmt-trials.org)
Bacterial infections are a serious problem for people who have liver cirrhosis – especially if the infection is resistant to antibiotics and cannot be treated.
The ...

Evusheld approved to prevent COVID-19 in people whose immune response is poor
People who have had a low immune response to the COVID-19 vaccine, including some patients with liver disease or liver cancer, may have access to a new prophylactic (intended to prevent disease) treatment.
Evusheld ...

Significant reduction in deaths from hepatitis C in England, UK Health Security Agency reports
A new report issued today by the UK Health Security Agency has revealed that there has been considerable progress in eliminating hepatitis C as a public health problem in England, with deaths from the virus falling by 35% between 2015 ...

Research shows alcohol purchases for the heaviest drinkers increased by 17 times during lockdown
New research has found that Britain’s heaviest drinkers bought around 17 times more alcohol from shops and supermarkets than the lowest purchasing households during the lockdown period of March to July 2020.
The data also ...

Health leaders issue stark warning to Prime Minister: Don’t U-turn on children’s health
The British Liver Trust has joined leaders from the UK’s largest health charities and medical organisations today to issue a warning to the Prime Minister, urging him to not dilute new laws which could prevent thousands of children ...

UK’s Early Access to Medicines Scheme now to be put on a legal footing
The Early Access to Medicines Scheme (EAMS) is a vitally important scheme that gives patients with life-threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation, when there is ...

Cancer survival gap still deadly
New data published by the NHS for the survival rates of adults diagnosed with cancer in England shows that there are still vast disparities in survival chances for people diagnosed with certain cancers.
Although overall cancer ...

This World Cancer Day, the British Liver Trust is calling for global improvements in liver cancer prevention, detection and care

The British Liver Trust supports campaign to recruit people to take part in COVID-19 treatment clinical trial
Adults over the age of 50 or with an underlying health condition, including people with liver disease, who test positive for COVID-19 are being urged to sign up for a world-first COVID-19 study which is providing life-saving ...

Transplant recipients invited to take part in new COVID-19 antibody study
If you have had a transplant, you’re aged 18 or over and have had (or are about to have) your third COVID-19 vaccine, you might like to consider taking part in a new study called the ‘Melody’ study.
What is the study about?
The ...

Charity calls for people in the UK to pledge to improve their liver health in 2022 following surge in liver disease deaths
The latest data reveals that deaths from liver disease in UK increased by an alarming 15% in 2020.1 Across the UK, 10,883 adults died of liver disease in 2020 - 30 people every day - compared to 9,470 deaths in 2019.
90% of these ...
No results found.
More from Liver UK

Check your risk
Find out if you’re at risk of liver disease using our simple at-risk checker for adults.
Find out more

Support us
Make a donation to help ensure everyone affected by liver disease gets the information and support they need.
Find out more

Keep up to date
Keep up to date with the charity’s news by registering for our email newsletter & updates.
Find out more
No results found.